Indaba Capital Management, L.P. Standard Biotools Inc. Transaction History

Indaba Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.87 - $2.78 $155,518 - $231,198	-83,165 Reduced 1.12%	7,363,064 $20 Million
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $7.55 Million - $13.6 Million	1,915,629 Added 34.64%	7,446,229 $33.7 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $8.54 Million - $13.6 Million	1,566,848 Added 39.53%	5,530,600 $33.2 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $266,004 - $760,627	143,786 Added 3.76%	3,963,752 $15.9 Million
Q1 2020 May 15, 2020	BUY	$1.24 - $4.35 $616,252 - $2.16 Million	496,978 Added 14.96%	3,819,966 $9.7 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $1.38 Million - $3.08 Million	601,700 Added 22.11%	3,322,988 $11.6 Million
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $10.7 Million - $28.2 Million	2,321,288 Added 580.32%	2,721,288 $12.6 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $2.87 Million - $3.53 Million	400,000 New	400,000 $3.45 Million

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $89.7M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Indaba Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Indaba Capital Management, L.P. with notifications on news.